Dataset: Gene-expression profiles of ovarian cancer regarding its microenvironment
PD-L1 suppresses host immunity and promotes tumor growth. We investigated how IFN-γ regulates PD-L1 in the ovarian cancer...
PD-L1 suppresses host immunity and promotes tumor growth. We investigated how IFN-γ regulates PD-L1 in the ovarian cancer microenvironment. In clinical samples, the number of stromal CTLs in peritoneally disseminated tumors was correlated with PD-L1 expression on the tumor cells, and the lymphocyte number was significantly related to the IFN-γ signature score. In mouse models, PD-L1 was induced in peritoneal disseminated tumors, where lymphocytes were prominent, but not in subcutaneous tumors. Depleting IFNGR1 resulted in lower PD-L1 expression and longer survival in peritoneal dissemination model. Injection of IFN-γ into subcutaneous tumors increased PD-L1 expression and tumor size, and PD-L1 depletion abrogated tumor growth. These data suggest that IFN-γ works as a tumor progressor through PD-L1 induction. The source of IFN-γ in ovarian cancer microenvironment and its biological effect to the tumor cells is unclear. The immortalized human ovarian surface epithelial cell line, HOSE-E7/hTERT (HOSE) was treated with IFN-γ and expression microarray analysis was performed, and probes showing significantly higher values in IFN-γ-added group were termed “IFN-γ signature genes (295 probes)”. We then applied this signature to our ovarian cancer microarray data, which included 75 ovarian cancer clinical samples, by means of ss-GSEA. IFN-γ signature score was strongly correlated to the number of infiltrating CD4-positive or CD8-positive lymphocytes in the tumors. These data suggest that the IFN-γ in the ovarian cancer microenvironment is derived from lymphocytes, and an IFN-γ-rich microenvironment is strongly correlated to a lymphocyte-rich microenvironment. Genome-wide transcriptional changes in human ovarian cancer tissue were observed in different tumor immunological microenvironment.
- Species:
- human
- Samples:
- 12
- Source:
- E-GEOD-55512
- Updated:
- Dec.12, 2014
- Registered:
- Jul.11, 2014
Sample | MICROENVIRONMENT_CD4POSITIVE_CELL_NUMBER | HISTOLOGICAL SUBTYPE | AGE | MICROENVIRONMENT_CD8POSITIVE_CELL_NUMBER | FIGO STAGE |
---|---|---|---|---|---|
GSM1338415 | 6 | serous | 60-69 | 12 | 3c |
GSM1338414 | 1 | serous | 60-69 | 0 | 3c |
GSM1338413 | 4 | endometrioid | 30-39 | 66 | 4 |
GSM1338412 | 0 | mucinous | 60-69 | 7 | 1c |
GSM13384 | 48 | serous | 60-69 | 547 | 3c |
GSM1338410 | 6 | serous | 50-59 | 163 | 2a |
GSM1338409 | 13 | clear | 30-39 | 133 | 1a |
GSM1338408 | 56 | serous | 60-69 | 31 | 3c |
GSM1338407 | 0 | clear | 50-59 | 0 | 1c |
GSM1338406 | 23 | serous | 50-59 | 109 | 3b |
GSM1338405 | 41 | serous | 70-79 | 73 | 2c |
GSM1338404 | 1 | serous | 70-79 | 25 | 3c |